These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26591434)

  • 21. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New violet-excitable reagents for multicolor flow applications.
    Abrams B; Diwu Z; Guryev O; Suni M; Dubrovsky T
    Cytometry A; 2013 Aug; 83(8):752-62. PubMed ID: 23765858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric monitoring of residual disease in acute leukemia.
    Wood BL
    Methods Mol Biol; 2013; 999():123-36. PubMed ID: 23666694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Morphology and immunophenotyping in hematological malignancies].
    Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
    Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accurate assessment of cell count and viability with a flow cytometer.
    Shenkin M; Babu R; Maiese R
    Cytometry B Clin Cytom; 2007 Sep; 72(5):427-32. PubMed ID: 17266154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies.
    Martínez A; Aymerich M; Castillo M; Colomer D; Bellosillo B; Campo E; Villamor N
    Cytometry B Clin Cytom; 2003 Nov; 56(1):8-15. PubMed ID: 14582132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Fossat C; Roussel M; Arnoux I; Asnafi V; Brouzes C; Garnache-Ottou F; Jacob MC; Kuhlein E; Macintyre-Davi E; Plesa A; Robillard N; Tkaczuk J; Ifrah N; Dombret H; Béné MC; Baruchel A; Garand R;
    Cytometry B Clin Cytom; 2015 Jan; 88(1):21-9. PubMed ID: 25363877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunophenotypic analysis of hematogones in patients with hematological malignancies].
    Kobayashi S; Kumagai R; Omiya A; Tanno H; Ishii Y; Yamamoto W; Takasaki H; Sakai R; Numata A; Matsumoto K; Tanaka M; Kanamori H; Motomura S; Maruta A
    Rinsho Ketsueki; 2012 Aug; 53(8):753-9. PubMed ID: 22975815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface-enhanced Raman scattering dye-labeled Au nanoparticles for triplexed detection of leukemia and lymphoma cells and SERS flow cytometry.
    MacLaughlin CM; Mullaithilaga N; Yang G; Ip SY; Wang C; Walker GC
    Langmuir; 2013 Feb; 29(6):1908-19. PubMed ID: 23360230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel full-spectral flow cytometry with multiple spectrally-adjacent fluorescent proteins and fluorochromes and visualization of in vivo cellular movement.
    Futamura K; Sekino M; Hata A; Ikebuchi R; Nakanishi Y; Egawa G; Kabashima K; Watanabe T; Furuki M; Tomura M
    Cytometry A; 2015 Sep; 87(9):830-42. PubMed ID: 26217952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunophenotyping of haematologic malignancies].
    Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application and usefulness of flowcytometry in the haematology laboratory].
    Kubota K; Makino M
    Rinsho Byori; 1991 Feb; 39(2):167-72. PubMed ID: 2041214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advancements of flow cytometry: new applications in hematology and oncology.
    Woo J; Baumann A; Arguello V
    Expert Rev Mol Diagn; 2014 Jan; 14(1):67-81. PubMed ID: 24308362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunophenotypization by means of flow cytometry in pathology].
    Manďáková P; Candová J
    Cesk Patol; 2013 Oct; 49(4):126-30. PubMed ID: 24289482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resolving and classifying haematopoietic bone-marrow cell populations by multi-dimensional analysis of flow-cytometry data.
    Zamir E; Geiger B; Cohen N; Kam Z; Katz BZ
    Br J Haematol; 2005 May; 129(3):420-31. PubMed ID: 15842667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry.
    Greig B; Oldaker T; Warzynski M; Wood B
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S23-33. PubMed ID: 17803190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometry in clinical pathology.
    Virgo PF; Gibbs GJ
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):17-28. PubMed ID: 22028426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.